Duodenal Bulb Adenocarcinoma Benefitted from Neoadjuvant Chemotherapy: A Case Report

Duodenal bulb adenocarcinoma is an extremely rare malignancy in the alimentary tract which has a low incidence rate and nonspecific symptoms. It is difficult to diagnose early, and the misdiagnosis rate is high. CT, MRI, upper gastrointestinal endoscopy, and other advanced imaging modalities should be combined to make a comprehensive evaluation. The diagnostic confirmation of this tumor type mainly depends on the pathological examination. The combination of surgery with other treatment modalities is effective. A review of reports on duodenal bulb adenocarcinoma with chemotherapy revealed 6 cases since 1990. However, there are few reports on neoadjuvant chemotherapy for the disease. In this report, preoperative S-1 in combination with oxaliplatin neoadjuvant chemotherapy achieved a complete pathological response in the treatment of duodenal bulb adenocarcinoma. Neoadjuvant chemotherapy shows a better clinical efficacy in the treatment of duodenal bulb adenocarcinoma, but its value needs to be further verified.

[1]  V. Heinemann,et al.  New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin , 2016, Chemotherapy.

[2]  H. Ohdan,et al.  A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II study , 2016, SpringerPlus.

[3]  Kyeong Ok Kim,et al.  [Endoscopic Resection of Sporadic Non-ampullary Duodenal Neoplasms: A Single Center Study]. , 2016, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[4]  Lijun Wang,et al.  S-1 treatment leading to complete remission of advanced duodenal adenocarcinoma: A case report. , 2015, Molecular and clinical oncology.

[5]  A. Shinagare,et al.  Diagnosis and management of duodenal adenocarcinomas: a comprehensive review for the radiologist , 2015, Abdominal Imaging.

[6]  Youming Li,et al.  Uncurable duodenal bulb ulcer-may be duodenal bulb cancer. , 2015, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[7]  B. Stabile,et al.  Duodenal Adenocarcinoma: Why the Extreme Rarity of Duodenal Bulb Primary Tumors? , 2014, The American surgeon.

[8]  H. Han,et al.  Clinicopathological analysis and survival outcome of duodenal adenocarcinoma , 2014, The Kaohsiung journal of medical sciences.

[9]  Huang Xiuhai.  A case report of primary adenocarcinoma at duodenal bulb diagnosed by endoscopy , 2014 .

[10]  Y. Takeyama,et al.  A Case of Adenocarcinoma of the Duodenum Arising from Brunner's Gland , 2013, Case Reports in Gastroenterology.

[11]  M. Overman,et al.  Small bowel adenocarcinomas—existing evidence and evolving paradigms , 2013, Nature Reviews Clinical Oncology.

[12]  J. Donohue,et al.  Neoadjuvant Treatment of Duodenal Adenocarcinoma: A Rescue Strategy , 2011, Journal of Gastrointestinal Surgery.

[13]  E. Sasaki,et al.  Successful treatment of duodenal adenocarcinoma with multiple liver metastases by S-1 + irinotecan (CPT-11) , 2009, Clinical journal of gastroenterology.

[14]  M. Overman.  Recent advances in the management of adenocarcinoma of the small intestine. , 2009, Gastrointestinal cancer research : GCR.

[15]  F. Itoh,et al.  Remission of Primary Duodenal Adenocarcinoma with Liver Metastases with S-1 Chemotherapy , 2007, Digestive Diseases and Sciences.

[16]  Y. Maehara,et al.  An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers , 1999, Oncology.